Metolazone
- Product NDC
- 50742-349
- 11-digit product format
- 507420349
- Labeler code
- 50742
- Product ID
- 50742-349_40a518ac-5d45-4c61-e063-6294a90a6ec9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metolazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals LLC
- Application
- ANDA215616
- Marketing category
- ANDA
- Marketing start
- 2023-01-24
- Substance
- METOLAZONE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metolazone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOLAZONE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | TZ7V40X7VX |
| Rxcui | 197978, 197979, 311671 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50742-349-01 | Metolazone | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-349 | METOLAZONE (METOLAZONE) TABLET [INGENUS PHARMACEUTICALS LLC] | 6 | Current NDC, 1 package rows | 20241215_1e566c10-4498-4f79-8874-4cc8c4216213.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50742-349-01 | 50742034901 | 100 TABLET in 1 BOTTLE (50742-349-01) | 100 tablet | 2023-01-24 | No | No | Current |